Searched for
ANTI CANCER MOLECULE
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Scientists just found the holy grail gene that could let humans regrow their own limbs one dayScientists studying naked mole rats discovered a gene linked to high levels of high molecular weight hyaluronic acid (HMW-HA), a substance ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Godavari Biorefineries secures Chinese patent for breakthrough anti-cancer moleculeGodavari Biorefineries received a patent from China for its new anti-cancer molecule. The China National Intellectual Property Administrati...
- From Pharaoh’s curse to cancer cure: Deadly Tutankhamun’s tomb fungus may turn out to be a blessing in disguiseResearchers have discovered that Aspergillus flavus, a toxic fungus previously associated with the "curse of the pharaohs," produces compou...
- IIT researchers find new molecule that can be used as targeted therapy to treat prostate cancerThe molecule has shown potency in cells to completely reduce tumour in 50 days.
- Technology varsity in Madhya Pradesh 'discovers' anti-cancer moleculesBhopal-based RGPV announced that it has applied for a US patent of the discovery of the new anti-cancer molecules code named "CTR-17 and CT...
- Indian biologists discover molecules with life-saving propertiesA new effort has also been launched by the Ministry of Earth Sciences to look for similar new molecules but from the high altitude Himalaya...
- Self-assembling anti-cancer molecules created in minutesResearchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of th...
- India's drug discovery and development: Small research firms aim to change face of cancer therapyIndia is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.
- High cholesterol fuels growth and spread of breast cancerThe research for the first time explains the link between high cholesterol and breast cancer, especially in post-menopausal women.
- AstraZeneca stock rallies as patent plea for cancer drug rejectedShares of AstraZeneca were witnessing selling pressure on reports that’s its patent plea on anti-cancer drug Gefitinib were rejected.
- Piramal completes Phase-I trials of new cancer moleculePiramal Healthcare today said it has completed the first phase of clinical trials of a new oral drug for treating cancer and will move to t...
- Actis Biologics starts phase-III trials of cancer drugBiotech firm Actis Biologics today said that Angiozyme, its biotech molecule targeted at colorectal cancer has entered into the third phase...
- Nich Piramal, institutions tie up for biological drugsDrugmaker Nicholas Piramal India Ltd said on Friday its research unit has tied up with the Department of Biotechnology to identify biologic...
- Panacea Biotec to enter oncology segmentBiotech firm Panacea Biotec on Thursday said it is planning to foray into oncology segment.
- Biocon may launch new anti-arthritis drugLeading biotech company, Biocon Limited on Monday said it expects to launch a new anti-arthritis drug in the next 3-4 years in the market, ...
Load More
